American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer
The guidelines recommend thromboprophylaxis for hospitalized medical and surgical cancer patients at high risk for VTE and low risk for bleeding, using LMWH or DOACs in various settings. They also emphasize individualized treatment decisions based on patient-specific factors, balancing the risk of VTE recurrence with bleeding complications.
advancesadv2020003442c.pdf